Submitted By Judith Weir on behalf of the Health and Education Committee, Cavalier King Charles Spaniel Club of Canada
There are many articles that address this disorder in great detail. We have attached such an article (below) to this overview for your convenience. This article is written by Dr. Clare Rusbridge and contains an authoritative explanation to the most commonly asked questions.
Dr. Clare Rusbridge, a European Specialist in Neurology, has
initiated a DNA Blood Collection Project on an international level. Dr.
Rusbridge has written two research papers on this disorder and both
were published in the American Journal of Veterinary Medicine. Reprints
are available from her associate, Penny Knowler, with proceeds to go
towards SM research. This project is supported by the Cavalier Club in
the UK and is partially funded by a grant from Boehringer Ingelheim.
All DNA/Blood is now being centralized at the McGill University Health
Centre in Montreal, Quebec - Canada with Dr. Guy Rouleau as the
principal investigator. Dr. Rouleau and his Canadian team will be
analyzing the data collected.
Due to the wonderful insight from committed owners, breeders and
veterinarians from around the world, amazing progress has already been
made. Updates are available from the UK website:
http://www.thecavalierclub.co.uk and will also be posted to our
Canadian National website: http://www.cavaliercanada.com. As we
receive new updates we will also be publishing them in our bi-monthly
news "Quotes" which is mailed to our members.
Although it appears this condition has been around for a number of
years, it is only recently that active research has begun. The Cavalier
King Spaniel Club of Canada, Health and Education Committee, has been
actively addressing this recently diagnosed condition by publishing
articles in our club's Quotes Newsletter on an ongoing basis. Because
DNA collection (blood) is what the researchers are requesting at this
time and because we wish to show our support for Dr. Rusbridge's
research project, this committee did undertake the task of organizing
our first DNA Blood Collection clinic - held on December 12, 2004 at
the Graham Animal Hospital, Hillsburgh, Ontario - just west of Toronto.
An email was sent to those members considered to be within driving
distance. See Cavalier Central homepage for specific details at
http://www.cavaliercanada.com. Our first effort was a huge success
and our goal to have in excess of 26 donors (who have fallen into the
most desirable category) of target cavaliers was exceeded as we had 32
donors. Target dogs are:
- Cavaliers that are symptomatic for the following diseases and their immediate relatives sire, dam, siblings and offspring:
Syringomyelia - symptoms of Syringomyelia vary – they can be mild or severe –see the Club information sheet (with or without MRI results)
MVD less than 5 years and/or their immediate relatives
Epilepsy
- Top winning/producing Dogs and Bitches that frequently appear in pedigrees
- Cavaliers 7 years and over with "clear" hearts (either a board
certified Cardiologist or a general practitioner veterinarian
evaluation qualify)
In addition to meeting the above qualifications, participants will
also be required to provide the following supporting documents:
- Phenotype Form (with "Consent" at bottom of page);
- 5 generation pedigree
- Any supporting medical records that may be available (eg MRIs, cardiologist reports, vet reports)
Those wishing to participate in Dr. Rusbridge's DNA Blood Collection
project may do so either through a sponsored/organized clinic or by
acting independently through their own veterinarian. The appropriate
and necessary forms are available through this website:
http://www.candog.com/cavaliers/ or by requesting information and
obtaining such forms from our designated Canadian contact person - Pat
Barrington (Chairperson of the Health and Education Committee of the
Cavalier King Charles Spaniel Club of Canada), at: harley2@sympatico.ca
These forms can be emailed to you. These forms are also available in a
downloadable format from the UK website; however some of the
information on these forms is not relevant to Canadian use.
Regional Cavalier Clubs are encouraged to hold a clinic in their
area. The Health and Education Committee is more than willing to offer
guidance.
Special thanks to Dr. Carol Graham and Dr. Alison Jones who have
agreed to donate their veterinary facility, as well as the donation of
Dr. Jones' time and service to conduct a brief examination attending to
symptoms for Syringomyelia and performing an auscultation re: MVD and
to Lisa Lott (vet-technician) who has also agreed to donate her time
and service in memory of her cavalier. It is important to mention that
this blood draw will address DNA research for more than that of
Syringomyelia. This blood draw will also provide DNA information for
research towards MVD and epilepsy.
Syringomyelia
By: Clare Rusbridge BVMS DipECVN MRCVS
What is Syringomyelia?
Syringomyelia (SM) is a progressive neurological disease that varies
in severity. Some refer to SM as "neck scratcher's disease" because
scratching in the air near the neck is often a sign of the disease,
especially when on a leash. It is similar to the human condition,
Chiari type 1 malformation (or Arnold Chiari in some older texts).
What causes it?
It is typically due to occipital hypoplasia (malformation of the
bone at the back of the skull which is too small). The smaller sized
bone changes the shape of the skull so that the brain is squashed
inside. The cerebellum (part of hind brain which co-ordinates movement
and balance) is forced into the foramen magnum (small opening at the
back of the skull which leads into the spinal cord) is kinked.
Cerebrospinal fluid, which is around the brain and spinal cord, moves
back and forth through the foramen magnum with the arterial pulse and
with changes in chest or abdomen internal pressure (e.g. barking). When
there is occipital hypoplasia the foramen magnum is obstructed, the
fluid cannot move to and fro easily and is forced into the spinal cord
creating a cavity or cavities (syrinxes) resulting in the condition
called syringomyelia. Since it was caused by occipital hypoplasia, it
is referred to as ‘Syringomyelia secondary to occipital hypoplasia'.
Most cavaliers have a degree of occipital hypoplasia but they don't all
get syringomyelia.
How do I know if my dog has Syringomyelia?
The only way to confirm a diagnosis is by MRI (Magnetic Resonance
Imaging). This is essentially a picture of the water content of the
body presented in a series of slices (like a loaf of bread). Nervous
tissue, which contains a lot of water, is not imaged by x-rays but is
shown in great detail by MRI. The syringomyelia can be easily
visualized as a pocket of fluid within the spinal cord. In severe cases
the syrinx is so wide that only a thin rim of spinal cord remains.
What clinical signs can the vet look for if I choose not to have an MRI?
Typically clinical signs are only seen when there is syringomyelia.
The damage to the spinal cord and the interruption of CSF flow results
in pain and abnormal sensations of which the most common signs are
crying and shoulder scratching, especially when excited or walking on a
lead. The scratching is usually to one side but may become both. There
is not evidence of skin or ear infections. Unlike scratching for skin
disease the dogs often walk and scratch at the same time and make
little contact with the skin.
Affected dogs are also sensitive around the head, neck and
forelimbs. They often cry/yelp/scream for apparently no reason (some of
these dogs may have unfair reputations for being a baby). Pain may be
related to head posture and some dogs prefer to sleep or eat with their
heads up. Excitement, barking, coughing, suddenly rising or exertion
can increase the fluid pressure in the syrinxes and precipitate the
scratching and/ or crying. Some severely affected young dogs develop a
neck scoliosis i.e. their neck is twisted. Other affected dogs may
develop a wobbling hind limb gait (pelvic limb ataxia) and/or a
forelimb weakness (thoracic limb weakness). Signs are usually
recognized between 6 months and 3 years however dogs of any age may be
presented. Mildly affected dogs may only have occasional signs of pain.
If my dog has been diagnosed with Syringomyelia what are the options?
No one can make the decision for you about what is best for your dog.
Medical management
Medical management can help but typically does not resolve the
clinical signs. Signs in mild cases may be controlled by non steroidal
anti-inflammatory drugs (Naiads) e.g. Rimadyl. Corticosteroids are very
effective in reducing signs partly because of the effect on reducing
CSF pressure and possibly because of a direct effect on chemicals which
mediate pain. Although corticosteroids are effective in limiting the
signs most dogs require continuous therapy and subsequently develop the
concomitant side effects of immunosuppression, weight gain and skin
changes. If there is no alternative then use the lowest possible dose
to control signs. For a CKCS the typical dose would be 5mg prednisolone
or 4mg methylprednisolone daily/on alternate days. Gabapentin
(Neurontin; Pfizer) is successful in some dogs. This drug, originally
patented as an anticonvulsant, is licensed as a neurogenic analgesic
for humans. Gabapentin, and other anticonvulsants suppress the firing
of hyper excitable damaged nervous system. The canine dose is 10-20
mg/kg two/three times daily which for a CKCS typically works out at a
dose of 100mg two/three times daily. Gabapentin can also be given in
combination with NSAIDs. Sedation may be seen, especially at higher
does, otherwise the side effects are minimal and on this basis the
authors' prefer Gabapentin over corticosteroids. The main disadvantage
of Gabapentin is that it is expensive and not licensed for dogs. Oral
opioids are also an alternative for example pethidine tablets at 2 –
10mg/kg three to four times daily or methadone syrup at 0.1 – 0.5mg/kg
three to four times daily. Acupuncture appears to help some dogs.
Surgical management
SM is a surgical disease – the most appropriate management is to
open the foramen magnum by removing a portion of the occipital bone and
usually part of the first vertebrae (foramen magnum decompression
surgery). The aim of surgery is to reduce the pain improving the dog's
quality of life and/or to stop or reduce further progression. If
neurological damage has already occurred, the surgery may not reverse
the damage and most dogs still have a tendency to scratch.
One must weigh the risks and benefits of surgery versus medication
versus no intervention. Remember, progressive disease means that no
action may enable further deterioration. When measuring the surgery's
success, measure from current condition to the expected further
condition – what the disease would have progressed to, rather than the
current condition only.
When to have surgery?
There is more chance of success if the surgery is done early in the
course of the disease before permanent damage has occurred. Surgery is
recommended for dogs with signs at less than 5 years old because
progressive disease is likely. In older dogs surgery is advised if the
dog is deteriorating.
What are the risks of surgery?
There are major blood vessels in the area and if traumatised the dog
could quickly bleed to death. Although not actually operating on the
brain/spinal cord, it is in close proximity and there is a risk of
permanent neurological injury. In reality complications from surgery
seem to be rare.
Can the disease recur?
In the authors' experience signs may recur in a proportion of dogs
after several months/years due to redevelopment of syringomyelia. The
newly created "space" from surgery may fill in with scar tissue. If
this happens, repeat surgery may be indicated; some owners prefer to
continue with medical management e.g. with NSAIDs, Gabapentin or
corticosteriods.
What post surgery drug treatment would advise?
Dogs are hospitalized until comfortable enough for
morphine-like-drugs to be discontinued and then discharged on a
combination of non steroidal anti-inflammatory drugs (e.g. Rimadyl) and
Gabapentin (Neurontin). This is withdrawn when the dog is comfortable
(about 2 weeks in most cases).
DNA collection program
Our aim is to provide a comprehensive, integrated collection of
Cavalier King Charles spaniel DNA for the benefit of the dogs, owners,
breeders and to provide insight into human disease. Surplus blood from
a health check would be stored for future studies on the health of the
breed. The current studies include Syringomyelia (SM), Mitral Valve
Disease (MVD) and Epilepsy.
Questions & Answers:
Why is blood needed?
It is easy to extract DNA from the white blood cells in a blood
sample. To do this the blood must be fresh and prevented from clotting
by putting it in an EDTA tube.
What will happen to the blood sample from a dog?
The DNA sample being submitted to the researchers will be anonymous
once it is entered into the archive and will be kept strictly
confidential. The samples and clinical data will be made available to
bona fide research groups working on these conditions and where the
projects have been deemed to be ethically sound. The owner will also
retain the right to remove the sample from the archive in the future if
so wished. However, no information regarding tests performed on the DNA
sample will be given back to the owner. It will only be possible to
find out which genes and environmental factors are important by
identifying patterns in large numbers of affected and unaffected
animals.
What kinds of dogs are needed to give blood?
All blood from Cavaliers will be valued. The purpose of the study is
to identify a gene through DNA analysis. We are therefore focusing on
certain areas to be most successful in achieving our goal. We need dogs
that are:
Normal healthy, especially if over 7 years or MRI confirmed normal (no SM)
Champions that often appear in pedigrees (any age)
SM Affected – MRI confirmed or showing typical clinical signs
Parents and siblings of affected dogs
Offspring of affected dogs – IF < 3 years of age the blood may be stored in case signs develop later.
Mates of an affected dog – is helpful if DNA from offspring is collected later
MVD affected and their relatives (see SM above)
Remember
Your blood donation will help keep Cavaliers healthy from inherited
diseases. SM/MVD carriers can have good genes/characteristics that we
need to conserve. The more help we get the speedier will be the result.
Why do I need to provide a pedigree?
Pedigree information about your Cavalier is important for our study.
The relationship between affected and non affected family members can
indicate the way in which a disease can be inherited. Comparisons are
made between the parental genotypes and those of the offspring.
Pedigree analysis is not sufficient in itself to determine if a trait
is inherited as a threshold trait. There are many investigations to be
made and that is why you are asked for as much blood (DNA) as possible.
Linkage may be used, which means DNA from animals that link up affected
individuals would be needed. Bottom line: It is essential that we have
DNA from related dogs regardless of whether their status is known.
Copyright: Clare Rusbridge BVMS DipECVN MRCVS
Disclaimer: Your veterinarian is the most qualified person to
answer all of the questions you have about your pet's health. Nothing in this article
should be construed as medical advice regarding any individual animal’s condition.
|